Fresenius Medical Care AG banner

Fresenius Medical Care AG
SWB:FME

Watchlist Manager
Fresenius Medical Care AG Logo
Fresenius Medical Care AG
SWB:FME
Watchlist
Price: 39.45 EUR 0.79%
Market Cap: €23.2B

Gross Margin

25.6%
Current
Improving
by 0.4%
vs 3-y average of 25.3%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
25.6%
=
Gross Profit
€5B
/
Revenue
€19.6B

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
25.6%
=
Gross Profit
€5B
/
Revenue
€19.6B

Peer Comparison

Country Company Market Cap Gross
Margin
DE
Fresenius Medical Care AG
XMUN:FME
22.5B EUR
Loading...
US
CVS Health Corp
NYSE:CVS
90.2B USD
Loading...
US
Cigna Group
XMUN:CGN
67.4B EUR
Loading...
US
Cigna Corp
NYSE:CI
69.1B USD
Loading...
DE
Fresenius SE & Co KGaA
XETRA:FRE
25.1B EUR
Loading...
US
Laboratory Corporation of America Holdings
NYSE:LH
21.7B USD
Loading...
US
Quest Diagnostics Inc
NYSE:DGX
21.5B USD
Loading...
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.5B EUR
Loading...
US
Guardant Health Inc
NASDAQ:GH
11.4B USD
Loading...
US
DaVita Inc
NYSE:DVA
10.4B USD
Loading...
US
Brightspring Health Services Inc
NASDAQ:BTSG
8.5B USD
Loading...

Market Distribution

Lower than 74% of companies in Germany
Percentile
26th
Based on 3 457 companies
26th percentile
25.6%
Low
-5 776.5% — 29.1%
Typical Range
29.1% — 60.9%
High
60.9% — 184.7%
Distribution Statistics
Germany
Min -5 776.5%
30th Percentile 29.1%
Median 44.6%
70th Percentile 60.9%
Max 184.7%

Fresenius Medical Care AG
Glance View

Fresenius Medical Care AG, a titan in the realm of healthcare, traces its origins back to Germany, where its journey began with an unwavering dedication to improving the lives of individuals suffering from chronic kidney failure. This imperative mission is at the core of its operations, merging compassionate patient care with cutting-edge technologies. As the leading provider of dialysis products and services globally, Fresenius Medical Care operates a vast network of renal care facilities, spanning continents, and serves a diverse patient base. The company designs and manufactures a comprehensive range of dialysis machines and related products, which are crucial to the life-sustaining process of cleansing blood when kidneys fail to function effectively. This seamless integration of service provision and product innovation underpins its success, creating a synergy that sets it apart in the healthcare sector. Revenue streams for Fresenius Medical Care are as diverse as they are robust, stemming from both its product line and its extensive network of clinics. The Clinics Division forms the backbone of its business model by offering treatment options directly to patients through a wide network of dialysis centers. Here, it garners revenue by billing healthcare providers and insurance companies for treatments administered. Meanwhile, its Products Division generates income by catering to both its proprietary clinics and third-party healthcare providers with dialysis equipment, consumables, and accompanying services. This dual-faceted structure ensures a steady flow of income, solidifying its position as an indispensable player in the global chronic kidney disease management landscape and making Fresenius Medical Care a stalwart in healthcare delivery systems worldwide.

FME Intrinsic Value
56.1 EUR
Undervaluation 30%
Intrinsic Value
Price
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
25.6%
=
Gross Profit
€5B
/
Revenue
€19.6B
What is Fresenius Medical Care AG's current Gross Margin?

The current Gross Margin for Fresenius Medical Care AG is 25.6%, which is above its 3-year median of 25.3%.

How has Gross Margin changed over time?

Over the last 3 years, Fresenius Medical Care AG’s Gross Margin has increased from 25.2% to 25.6%. During this period, it reached a low of 24.5% on Mar 31, 2025 and a high of 26.6% on Mar 31, 2023.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett